MedPath

Double ovarian stimulation (Shanghai and Duostim protocol)

Phase 3
Completed
Conditions
Poor ovarian response.
Complications of attempted introduction of fertilized ovum following in vitro fertilization
N98.2
Registration Number
IRCT20080831001141N35
Lead Sponsor
Royan Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Age =35 years
Antimullerian hormone (AMH) <1.2 ng/ml and/or antral follicular count=5 follicles
=4 oocyte retrieved from previous ART cycle
18.5<BMI<30

Exclusion Criteria

Endometriosis (stage III and IV)
Myoma with a compression effect
Uterine anomalies (Unicorn, Didelphis,etc,….)
Male factor infertility with azoospermia, severe oligospermia and oligoasthenospermia, TESE/PESA

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.